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Abstract Glomerular filtration rate (GFR) assesses kidney
function. GFR is measured by renal clearance techniques;
inulin clearance is the gold standard but is not easily
measured. Thus, other methods to determine GFR have
been utilized. Endogenous creatinine clearance (CrCl) is the
most widely used, but creatinine secretion falsely elevates
GFR. Cimetidine inhibits creatinine secretion, such that
CrCl equals GFR, provided there are no difficulties with
bladder emptying. Estimation of GFR from serum creati-
nine (e.g. Schwartz formula) is useful clinically; however,
such formulae have not been updated for enzymatic
creatinine autoanalyzers. Cystatin C, a small protein, is
produced at a relatively constant rate and is reabsorbed in
the proximal tubule. Cystatin C may be more sensitive than
creatinine in detecting a reduction in GFR, but further
studies are needed to prove this. Single injection (plasma)
clearance techniques are the most precise measures of GFR.
Iohexol is an exogenous marker that is comparable to inulin
and 51Cr-EDTA and can be measured by high-performance
liquid chromatography (HPLC). Our pilot and the Chronic
Kidney Disease in Children (CKiD) North American
studies show that iohexol can accurately measure GFR
using a four-point plasma disappearance curve national
studies show that iohexol can accurately measure GFR
using a four-point plasma disappearance curve (10, 30, 120,
and 300 min) or, in most cases, a two-point disappearance
time (120 and 300 min).
Keywords Iohexol . HPLC . KDOQI . Plasma clearance .
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Introduction
Chronic kidney disease (CKD) encompasses a continuum
of renal impairment characterized by decreasing glomerular
filtration rate (GFR). GFR is the most useful measurement
of kidney function. Other functions of the kidney, i.e.,
production of erythropoietin, activation of vitamin D, and
ion and solute transport also decline as GFR declines. GFR
represents the volume of plasma ultrafiltrate presented to
the nephrons per unit time in the process of urine formation.
GFR is measured indirectly through the concept of
clearance, which is defined as the equivalent volume of
plasma from which a substance would have to be totally
removed to account for its rate of excretion in urine per unit
of time. Clearance is calculated by dividing the excretion
rate of a substance by its plasma concentration (Cx=UxV/
Px) where Ux and Px are urine and plasma concentrations,
respectively, of substance x, and V is urine flow rate. When
the substance is freely filtered, and not protein bound, and
is not reabsorbed, secreted or metabolized by the kidney,
then Cx=GFR. Cx is expressed as milliliters per minute, and
is usually normalized to a standard 1.73 m2 idealized adult
body surface area (Cx in milliliters per minute per 1.73 m
2)
by the factor 1.73/BSA, where BSA is the body surface
area (in square meters) of the examined subject. Normal
values of GFR for infants, children, and young adults are
presented in Table 1 in milliliters per minute per 1.73 m2.
Although some authors have questioned the value of
normalizing GFR to body surface area, normalization
allows easy comparison to standard adult values for GFR
[1–3]. The most direct standard of reference would be
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kidney weight, but this is not available in clinical practice.
However, kidney weight bears a constant relation to body
surface area in animals and humans, indicating that the
surface area basis of comparison is the most useful [1].
Measurement of GFR is the best clinical test for
estimation of functioning renal mass. Knowledge of GFR
enables the clinician to prescribe fluids and solutes,
determine the progression of kidney disease, predict the
development of end-stage renal disease (ESRD), and
appropriately dose medications excreted by the kidney.
Physiology of glomerular filtration
Normal kidneys contain approximately two million glo-
merular capillary units [4–6]. Each glomerulus consists of a
tuft of capillaries interposed between the afferent and
efferent arterioles. The glomerular capillary wall is made
up of three layers: the fenestrated endothelial cell, the
glomerular basement membrane (GBM), and the epithelial
cell. The epithelial cells, podocytes, are attached to the
GBM by discrete foot processes. The slits between the foot
processes are covered by a thin membrane called the slit
diaphragm [4, 7, 8]. The GBM is derived from material
produced by endothelial and epithelial cells, including type
IV collagen, laminin, nidogen, and heparan sulfate proteo-
glycans. Laminin and nidogen form a tight complex to
promote cell adhesion. The anionic heparan sulfate proteo-
glycans may contribute to the electrical charge barrier to the
filtration of anionic macromolecules [4, 8].
One of the primary functions of the glomerulus is to
allow the filtration of small solutes, such as sodium and
urea and water, while restricting the passage of larger
molecules. This permits the kidney to maintain homeostasis
by excreting the nitrogenous waste derived from dietary
intake, while preserving the essential larger plasma protein
molecules. Solutes up to the size of inulin (mol. wt. 5,200)
are freely filtered, whereas myoglobin (mol. wt. 17,000) is
filtered less completely than inulin, and albumin (mol. wt.
69,000) is filtered only to a minor degree. Filtration is also
limited for ions or drugs that are bound to albumin.
GFR is determined by two factors: the filtration rate in
each nephron, also referred to as single nephron GFR
(SNGFR), and the number of filtering nephrons. Each
normal kidney in humans is endowed with approximately
one million nephrons at birth. Blood entering through the
afferent arteriole goes into the glomerular capillary tuft and
exits through the efferent arteriole. Along the glomerular
capillary tuft a portion of the glomerular plasma is
ultrafiltered into Bowman’s space, which, after being
processed by renal tubules and collecting ducts, leads to
the formation of urine. Fluid movement across the
glomerulus is governed by Starling’s forces, being propor-
tional to the permeability of the glomerular capillary wall
and to the balance between hydraulic and oncotic pressure
gradients.
Assessment of glomerular filtration rate
Since the total kidney GFR equals the sum of the SNGFRs
in each of the functioning nephrons, the total GFR can be
used as an index of functioning renal mass. Following
nephron loss, compensatory changes in surviving nephrons
are commonly observed in clinical practice. This leads to a
lesser loss of total renal function than anticipated by the
extent of anatomic damage. In fact, the earliest nephron
losses are likely to be invisible due to functional compen-
sation, which would bring GFR back into the normal range.
For example, a loss of half the functioning nephrons leads
to a decrease in GFR of only 20–30%, rather than the
anticipated 50% [9]. In most patients with early chronic
kidney disease (CKD), the fluid and electrolyte balance is
Table 1 Glomerular filtration rate in healthy infants, children, and
young adults as assessed by inulin clearance





1–3 days 14.0±5 [76]
1–7 days 18.7±5.5 [77]
4–8 days 44.3±9.3 [78]
3–13 days 47.8±10.7 [79]
8–14 days 35.4±13.4 [77]
1.5–4 months 67.4±16.6 [79]
Term babies
1–3 days 20.8±5.0 [77]
3–4 days 39.0±15.1 [80]
4–14 days 36.8±7.2 [81]
6–14 days 54.6±7.6 [82]
15–19 days 46.9±12.5 [77]
1–3 months 85.3±35.1 [80]
0–3 months 60.4±17.4 [83]
4–6 months 87.4±22.3 [83]
7–12 months 96.2±12.2 [83]
1–2 years 105.2±17.3 [83]
Children
3–4 years 111.2±18.5 [83]
5–6 years 114.1±18.6 [83]
7–8 years 111.3±18.3 [83]
9–10 years 110.0±21.6 [83]
11–12 years 116.4±18.9 [83]
13–15 years 117.2±16.1 [83]
2.7–11.6 years 127.1±13.5 [78]
9–12 years 116.6±18.1 [80]
Young adults
16.2–34 years 112±13 [84]
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well maintained, and even the urinalysis may be normal.
The decline in GFR may, therefore, be the earliest and only
clinical sign of renal disease. Serial monitoring of GFR can
be used to estimate severity and to monitor the course of
CKD.
Inulin clearance
Inulin, which has a mean molecular radius of 1.5 nm and a
molecular weight of approximately 5,200, is considered an
ideal marker and the gold standard for measuring GFR.
Inulin is freely filtered, is not protein bound, is not
reabsorbed, does not affect kidney function, and is neither
secreted nor metabolized by the kidney. When injected
intravenously, inulin clearance equals GFR (Cx=CIn=GFR)
[10].
The classic (standard) inulin clearance requires an
intravenous priming dose of inulin, followed by a constant
infusion to establish a steady-state inulin plasma concen-
tration [11]. After an equilibration for ~45 min, serial urine
samples are collected every 10–20 min through an
indwelling bladder catheter. Insertion of an indwelling
urinary catheter might not be possible or justifiable in
current clinical practice; urine is obtained voluntarily in
such cases every 20–30 min, as dictated by the urge of the
patient to urinate. High urine flow is maintained throughout
the test by providing an initial oral water load of 500–
800 ml/m2 and replacing urinary water loss with oral intake
of water (milliliter-per-milliliter) [10]. Continuous infusion
clearances obviate the need for urine collection, as once a
steady state is achieved, the infusion rate is essentially
equal to the excretion rate [12].
The use of inulin clearances has a number of
limitations. First, some children may not be toilet trained
and are unable to provide accurate collections of timed
urine. Second, urologic problems are common causes of
CKD in infants and young children [13], and many of
these children have significant vesicoureteral reflux, neu-
rogenic bladders, or bladder dyssynergia. The collection of
timed urine in such patients is difficult and fraught with
error. Third, technical difficulties encountered in
performing inulin infusions, and reaching a steady state of
inulin distribution, are common. Lastly, inulin is not
currently readily available. These problems have rendered
the standard inulin clearance to be impracticable in
children.
Endogenous creatinine clearance and the use of cimetidine
Because of the difficulties with administering and measur-
ing inulin, standard endogenous creatinine clearances have
been used to estimate GFR. Creatinine results from the
enzymatic degradation of creatine synthesized in skeletal
muscle. Urinary excretion of creatinine is therefore a
product of muscle catabolism and hence an index of muscle
mass [14]. In the steady state, serum creatinine also
correlates well with muscle mass [15, 16]. Creatinine has
a molecular mass of 113 Da and is eliminated exclusively
by the kidneys via glomerular filtration and, to a lesser
extent, by tubular secretion. Endogenous creatinine clear-
ance provides an acceptable measurement of GFR for
clinical purposes and is calculated by the following
equation:
Ccr ¼ UcrV=Scr;
where Ccr is creatinine clearance, Ucr is urine creatinine
concentration, V is flow rate of urine in milliliters per
minute, and Scr is serum creatinine. The creatinine
clearance is normalized to body surface area (BSA) by
being multiplied by the factor 1.73/BSA in square meters.
The relative constancy of creatinine production and its
urinary excretion in the steady state helps one analyze for
completeness of the collection (creatinine excretion per
kilogram body weight). Urinary creatinine excretion should
generally be approximately 20 mg/kg per day in children
over 3 years of age (slightly higher in pubertal adolescent
boys) [14, 17–19], and values less than this indicate
incomplete urine collection or loss of some urine. Largely
because of difficulties in obtaining accurate urine collec-
tions (both under- and over-collection of 24 h urine can
occur), recent Kidney Disease Outcomes Quality Initiative
(KDOQI) guidelines state that “measurement of creatinine
clearance using timed urine collections does not improve
the estimate of GFR over that provided by prediction
equations” [20]. Daily variations in urinary creatinine
excretion for a given subject can result in standard
deviations of 10–15% [19, 21].
When creatinine clearance is performed by 24 h urine
collection, the child is asked to empty the bladder in the
morning (7 A.M.) of the day of the test; the urine is
discarded, and the time is noted as the start of the
collection. All urine voided in the next 24 h is collected
in the container as part of this collection. At the end of 24 h
(7 A.M. the next day) the bladder is emptied and the last
void is deposited in the container as the final part of the
collection. The volume of urine is noted accurately, and the
urine is analyzed for creatinine concentration. Blood (for
serum creatinine) is drawn once during this time period.
Averaging several short clearance periods (~30 min)
after water loading tends to minimize errors in urine
collection and improve supervision of the study [22]. Large
variations in urine creatinine excretion indicate significant
vesicoureteral reflux or problems in bladder emptying that
might warrant bladder catheterization to improve accuracy.
In addition creatinine concentration is affected by dietary
intake of meat, exercise, pyrexia and a variety of sub-
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stances. Patients are frequently asked to ingest a low-
protein diet prior to the creatinine clearance study, as
ingesting a protein load can change GFR. More impor-
tantly, it is well known that creatinine is secreted by the
renal tubules, and this secretory component accounts for
~10% of the urinary creatinine excretion in healthy
individuals [15]. Whereas urinary creatinine contributed
by tubular secretion does not normally exceed 10%, this
fraction rises greatly during chronic renal insufficiency, and
creatinine clearance may greatly exceed GFR, particularly
at low levels of GFR [11, 15].
The administration of cimetidine to patients with renal
disease causes a decrease in tubular creatinine secretion,
resulting in a creatinine clearance that approximates the level
of true GFR [23]. The protocol modified by Hellerstein and
colleagues used cimetidine for 3 days at a dose of 20 mg/kg in
two divided doses (maximum 1,600 mg per day and a sliding
scale dose reduction for decreased GFR) [24]. After a final
dose of half the daily dose and an oral load of 7–8 ml/kg of
fluids, urine is collected for approximately 2 h under
supervision [25]. Alternatively, urinary clearance during four
supervised periods of ~30 min, with replacement of urine
output, can be measured. While the cimetidine protocol is a
convenient, inexpensive procedure for estimating GFR, failure
to document bladder emptying by ultrasound, lack of toilet
training, and the presence of vesicoureteral reflux, neurogenic
bladders, and bladder dyssynergias can cause inaccuracies in
the results because of problems in urine collection.
Estimated GFR based on serum creatinine
The close relationship between creatinine clearance and
GFR on the one hand, and creatinine production and
muscle mass on the other, along with the difficulties of
collecting urine, have led to the concept of estimating GFR
from serum creatinine and some parameter of body habitus,
as detailed by Schwartz et al. [26]:
eGFR ¼ kL=Scr;
where eGFR is estimated GFR in milliliters per minute per
1.73 square meters, k is a constant determined empirically
by Schwartz and associates [27], L is height in centimeters,
and Scr is serum creatinine in milligrams per deciliter. This
formula is also based on the relationship that Ccr is
reciprocally proportional to the serum creatinine. A dimen-
sional analysis of k (milligrams creatinine/100 min×cm×
1.73 m2) indicates that k is equal to UCrV/L, which is
directly related to urinary creatinine excretion, which is, in
turn, proportional to lean body mass [18, 27].
The value of k is 0.45 for term infants during the first
year of life [18], 0.55 for children and adolescent girls [26],
and 0.7 for adolescent boys [17]. Such a formula generally
provides a good estimate of GFR (r~0.9) when compared
with creatinine and inulin clearance data [24, 26]. Interest-
ingly, at high values of GFR, the variation between inulin
clearance and GFR estimated by the Schwartz formula was
about 20%, but it was much smaller at lower levels of GFR
[24, 26]. It should be noted that these constants were
generated from creatinine values measured using a modi-
fication of the Technicon autoanalyzer method, which relies
on a Jaffe chromogen reaction to quantify creatinine.
Recently, Zappitelli et al. have published revisions of the
Schwartz formula relating eGFR to serum creatinine
determined enzymatically, using the creatinase methods
available in more modern autoanalyzers [28]. The enzy-
matic creatinine values generally run 10–20% lower than
those measured by the Jaffe method [29], and so one would
anticipate that “k” values should be comparably smaller
than those listed above. In the Zappitelli report, the “k”
value in the Schwartz equation decreased from 0.55 to 0.47
for children and adolescent girls [28]. In the Chronic
Kidney Disease in Children (CKiD) pilot study [30], and in
the baseline CKiD cohort of children aged 1 to 16 years
with mild to moderate CKD, estimated GFR using the
Schwartz formula and enzymatic creatinine overestimated
the GFR determined by the plasma disappearance of
iohexol by approximately 12 ml/min per 1.73 m2. Further
evaluation of baseline and longitudinal data on simulta-
neously obtained serum creatinine, other laboratory data,
body habitus parameters and iohexol-based GFR will lead
to refinements of GFR-estimating equations for children in
the CKiD study.
Counahan and colleagues [31] generated a similar
formula using “near-true” creatinine determinations in
children of varying ages, and the resulting k was 0.43.
The lower k value may reflect the lower value of creatinine
after removal of non-creatinine chromogen with an ion
exchange resin. Indeed, this k value is approximately 20%
smaller than that of the k obtained from the modified
Technicon autoanalyzer, which is in keeping with the
expected reduction in apparent serum creatinine concentra-
tion using the “true” method.
The estimated GFR formulae have some limitations and
should not be used for patients with severe obesity or
malnourishment or limb amputation, in whom body height
may not accurately reflect muscle mass [27]. Additionally,
these GFR estimate formulae are not accurate when GFR is
rapidly changing, such as in critically ill children or in acute
renal failure [32].
The Cockcroft–Gault equation [33], which is used to
estimate GFR in adults, may also be useful in children over
12 years of age [34].
e0GFR ¼ 140 ageð Þ body weight in kgð Þ= 72 Scrð Þ
where e’GFR is the estimated GFR using the Cockcroft–
Gault equation in males; in females a correction factor of
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0.85 is used. Whereas there is good overall agreement with
standard inulin clearances in children aged 12 years and
older, Cockcroft–Gault estimates are very different from
inulin clearances in younger patients. The formula for
adults, generated by the Modification of Diet in Renal
Disease (MDRD) group, is not useful in children [34].
Cystatin C
Cystatin C is a non-glycosylated 13 kDa basic protein that
acts as a cysteine proteinase inhibitor and is produced at a
relatively constant rate. This constancy is apparently not
influenced by the presence of inflammatory conditions,
muscle mass, gender, body composition, and age (after
12 months) [35, 36]. Blood cystatin C level is approxi-
mately 1 mg/l in healthy individuals [37]. Cystatin C is
catabolized and almost completely reabsorbed by renal
proximal tubular cells, so that little is excreted in the urine
[38] and cannot be used to calculate a clearance GFR.
Interindividual variation of cystatin C level is significantly
less (25%) than that of creatinine (93%) [39]. The upper
limit of the population reference interval for cystatin C is
seldom more than 3–4 SD from the mean value of any
healthy individual (compared with 13 SD for creatinine).
These findings suggest that cystatin C is potentially a better
marker than creatinine is for detecting impaired renal
function.
From a number of clinical studies of cystatin C [40],
including one in healthy children [35], two key findings are
evident. First, the concentration of serum cystatin C
correlated better with directly measured values for GFR
than did serum creatinine. Second, subtle decrements in
GFR are more readily detected by the determination of
serum cystatin C than by creatinine concentration [40].
Thus, while cystatin C is not a conventional marker of
GFR, reciprocal values of serum cystatin C levels are
reasonably well correlated with GFR in adults [41, 42] and
in children [29, 43–45].
Some studies have suggested that the serum concentra-
tion of cystatin C might be superior to serum creatinine in
distinguishing normal from abnormal GFR [46]. However,
because it is metabolized and not excreted, cystatin C
cannot be used to measure GFR by standard urinary
clearance techniques [40]. Nevertheless, serum cystatin
can be used to estimate GFR in milliliters per minute per
1.73 square meters according to the following formula [47]:
log10(GFR)=1.962+[1.123×log10(1/cysC)], where cysC is
cystatin C. Additional formulae using both cystatin C and
creatinine to estimate GFR have recently been reported [28].
Other studies have shown that plasma cystatin C is
slightly better than plasma creatinine in diagnosing renal
insufficiency but is less sensitive than creatinine clearance
or eGFR (from k×L/Pcr) [48]. Moreover, cystatin C levels
may underestimate GFR in renal transplant patients [49].
More recent studies have shown that factors other than
renal function, such as C-reactive protein (CRP) and
smoking status, may influence serum cystatin C concen-
trations, so that caution must be used when one is
interpreting serum cystatin C levels as a measure of renal
function [50]. The findings of cystatin C in the urine during
glomerular and tubular injury also casts some doubt on the
ability of serum cystatin C to accurately estimate GFR [51,
52].
Single-injection clearance techniques
The renal clearance of a substance that is not metabolically
produced or degraded, and that is excreted from the body
completely or almost completely in the urine, can be
calculated from compartmental analysis by monitoring its
rate of disappearance from the plasma following a single
intravenous injection [53]. The mathematical model for the
disappearance curve is an open two-compartment system.
The GFR marker is injected in the first compartment,
equilibrates with the second compartment, and is excreted
from the first compartment by glomerular filtration.
Initially, the plasma concentration falls rapidly but at a
progressively diminishing rate, as there is diffusion of the
marker in its distribution volume as well as its renal
excretion. Thereafter, the slope of the decline of plasma
concentration predominately reflects its renal excretion rate.
This latter decrease occurs at the same exponential rate in
the compartments wherein it is distributed.
The plasma disappearance curve can be resolved into
two exponential decay curves by plotting the logarithm of
the plasma concentration as a function of time and applying
the technique of curve stripping (Fig. 1). The terminal slow
(renal) portion of the curve (line A) is extrapolated back to
zero time, and its Y intercept (A) and slope (α) are
determined. When the values along line A are subtracted
from the original curve, a second linear function (line B) is
obtained. Its Y intercept (B) and slope (β) are also noted.
The clearance of the substance (GFR) can be calculated as
[53]:
GFR ¼ Dose= exp Að Þ=αþ exp Bð Þ=βð Þð½ 1:73=BSA:
where Dose is the administered amount of GFR marker,
and GFR is normalized to 1.73 m2 by being multiplied by
1.73/BSA. Because all the dosed marker is excreted in the
urine, this equation essentially resembles the familiar
GFR=UV/P. To obtain an accurate plasma disappearance
curve, one requires several blood samples. Extension of
sampling to 5 h is essential to assure accuracy at low levels
of GFR.
Excellent and comparable results may also be obtained
using the one-compartment (renal curve) model, by which
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samples are obtained 2–5 h after injection, as described by
Brochner-Mortensen [54]:
GFR ¼ C1 GFR Að Þ þ C2 GFR Að Þ½ 2;
where GFR (A)=Dose/[exp (A)/α], and C1=0.9908 and
C2=−0.001218, as generated by Brochner-Mortensen in
adults by comparing with plasma disappearance curves for
51Cr-EDTA. Similar constants have been generated for
children by Brochner-Mortensen [55], using comparable
methodology (C1=1.01; C2=−0.0017), and recently by us
in the CKiD pilot study [30] (C1=0.9950; C2=−0.001159).
Whether or not the one-compartment model is accurate in
patients with large amounts of edema and ascites has not
been systematically examined.
Exogenous markers used for single-injection clearance
measures: diethylene triamine penta-acetic acid,
ethylene diamine tetra-acetic acid, and iothalamate
Historically, the plasma disappearance curve was most
often used when GFR was assessed with radionuclides
(Table 2). Even with single-injection techniques, radioac-
tive markers are best avoided in small children. Diethylene
triamine penta-acetic acid (DTPA) has a molecular mass of
393 Da and is excreted primarily by glomerular filtration.
GFR can be measured in each kidney with a scintillation
camera and the 98mTc-DTPA complex; however, the
correlation with 24 h creatinine clearances is only fair
[56]. It should be noted that the plasma clearance of 99mTc-
DTPA significantly exceeds the urinary clearance [57, 58].
On the other hand, the plasma clearance of 99mTc-DTPA
correlates well with the renal clearance of inulin [58].
Failure to accurately measure GFR may reflect the fact that
the 99mTc can dissociate from the DTPA during the study,
and there can be variations in protein binding depending on
the ligand attached to DTPA [59]. Some preparations with
99mTc-DTPA gave results comparable to those with 51Cr-
EDTA, while others underestimated GFR by 7–22% [59].
Thus, the accuracy of 99mTc-DTPA may depend on the
commercial source.
Estimation of GFR by use of radioisotopes is a common-
ly used technique in children, particularly with the limited
availability of inulin and difficulties in collecting accurate
timed urine in children. The most commonly used radioiso-
tope is 99mTc-DTPA. One method calculates GFR from the
uptake of labeled tracer in each kidney and allows determi-
nation of separate assessment of each kidney separately
(split functions) [56]. A second method utilizes the disap-
pearance of the labeled marker from the plasma, and, as
noted above, DTPA is variably accurate as a marker of GFR.
Ethylene diamine tetra-acetic acid (EDTA) is another
glomerular marker, with a molecular mass of 292 Da, and is
used as a chelate of 51Cr, primarily in Europe. Its plasma
clearance exceeds its urinary clearance by ~6 ml/min,
particularly in patients with reduced renal function [58].
However, plasma clearance of 51Cr-EDTA agrees well with
that of renal inulin clearance [58], indicating that it is a
good marker for GFR. Values of 51Cr-EDTA plasma
clearances increase from birth to age 18 months and,
thereafter, they plateau. The absolute numbers agree well
with measurements performed using inulin clearances.
Iothalamate sodium has a molecular mass of 636 Da. It
has been used as 125I-radiolabeled or without radioactive
label, its non-radioactive serum concentration being mea-
sured by X-ray fluorescence, high-performance liquid
chromatography (HPLC), or by capillary electrophoresis.
In a comparison of agents, the plasma clearance of 125I-
iothalamate was 13% higher than that of 51Cr-EDTA [60].
The difference was reduced by pretreatment of the patients
with probenecid, an organic anion secretory inhibitor.
Extensive laboratory studies have shown unambiguously
that iothalamate is actively secreted by renal proximal
tubular cells and may also undergo some tubular reabsorp-
tion [60]. The renal clearance of iothalamate significantly
























Fig. 1 Disappearance of
iohexol as a function of time
after injection into the blood.
The natural logarithm of the
iohexol concentration is plotted
against the time in minutes. The
curve can be stripped into two
components, the slow or renal
curve with slope α and intercept
A. When those points are sub-
tracted from the initial curve, a
straight line with a steeper slope
β defines the fast or distribution
curve with intercept B
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[61], and any reported agreement with inulin clearance may
reflect a fortuitous cancellation of errors between tubular
excretion and protein binding [62]. Another factor affecting
comparability of inulin and iothalamate is the Gibbs
Donnan distribution, enhancing anionic iothalamate clear-
ance by about 5%. Thus, iothalamate cannot be recom-
mended as an ideal marker for measuring GFR.
Iohexol
A reliable alternative to inulin clearance avoids both the
use of radioactivity and the problems related to timed
urination and continuous infusion of the marker. Iohexol,
a non-ionic, low osmolar, X-ray contrast medium (Omni-
paque) that is safe and non-toxic and used in angiographic
and urographic procedures, is eliminated from plasma
exclusively by glomerular filtration [63]. Iohexol has a
molecular mass of 821 Da, a plasma elimination half-time
of ~90 min, is distributed into the extracellular space and
has less than 2% plasma protein binding [63, 64]. Iohexol is
excreted completely unmetabolized in the urine, with 100%
recovery within 24 h after injection [65]. Extrarenal
elimination of iohexol in a setting of reduced GFR is
negligible [66]. Since iohexol can be quantified in small
samples, capillary, as well as venous, sampling can be
employed [67]. A recent report by Niculescu-Duvaz et al.
[68], suggests that, in the future, finger stick sampling,
followed by automated HPLC analysis of blood spots
collected on filter paper, may become a clinically viable
option for measuring GFR with iohexol. Iohexol is
measured in deproteinized plasma or serum by HPLC or
X-ray fluorescence.
The commercially available preparations contain two
isomers of iohexol, both of which are handled similarly by
the body [67, 69]. In practice, the major peak, eluting at
about 5 min, is used for determining serum/plasma
concentrations [69]. Most studies indicate close agreement
between GFR (measured by inulin clearance) and clearance
of iohexol, measured as standard renal clearance or plasma
disappearance [65, 69–72]. There is not only a very good
correlation between plasma iohexol clearance and that of
51Cr-EDTA, but also no difference between the methods by
Bland-Altman analysis [73]. Direct comparison with iotha-
lamate indicates that the iothalamate clearance exceeds that
of iohexol by 19% [63].
Modeling of plasma disappearance of iohexol shows that
its excretion conforms to a two-compartment open system
[65, 69]. In a pilot study for the National Institutes of
Health (NIH)-supported Chronic Kidney Disease in Chil-
dren (CKiD) study, we have found that, even with low
GFR, serum iohexol concentrations decrease exponentially
along the slow (renal) curve within 60–120 min of injection
[30]. The clearance of iohexol (GFR) may also be
calculated from the slow (renal) plasma disappearance
curve (one-compartment system approximation beginning
120 min after injection) according to the method of
Brochner-Mortenson (see above), [54] or by applying the
Chantler correction, which assumes a constant correction
factor of 0.87 [74, 75]. In the CKiD GFR pilot study [30],
calculation of the urinary clearance of iohexol was less
precise than the plasma disappearance of iohexol, because
of variability in the urine collections, with a median
standard deviation between urine collection periods within
an individual of approximately 24%.
Questions
(Answers appear following the references.)
1. What is the most accurate method for determining GFR






2. When are estimate GFR formulae least accurate?
A) When subject is less than 10 years old
B) When subject is obese
C) When renal function is rapidly changing
D) When subject is volume contracted
E) When subject has recently used gentamicin
3. Which method is most useful for measuring GFR in
children who may have underlying vesicoureteral
reflux or bladder emptying problems?
A) MDRD estimate equation
Table 2 Properties of markers of glomerular filtration (M.M. molecular mass, Elim. elimination, ECW extracellular water, TBW total body water,
EDTA ethylene diamine tetra-acetic acid. Data adapted from [72]
Property Inulin Creatinine Iothalamate DTPA EDTA Iohexol
M.M. (Da) 5,200 113 636 393 292 821
Elim. half-life (min) 70 200 120 110 120 90
Protein binding (%) 0 0 <5 5 0 <2
Space distribution ECW TBW ECW ECW ECW ECW
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B) Classical renal inulin clearance
C) 24 h creatinine clearance
D) Nuclear renal imaging
E) Plasma disappearance
4. Cystatin C
A) Acts as a cysteine proteinase promoter
B) Levels are substantially influenced by muscle mass
and age
C) Is catabolized and almost completely reabsorbed
by renal proximal tubular cells.
D) Is produced by breakdown of creatine
E) Can be used to measure GFR using standard
urinary clearance measurement
5. Which of the following radionuclides is useful for GFR
measurement?
A) 99mTc-DTPA (diethylene triamine penta-acetic acid)
B) 125I-Hippuran
C) 99mTc-MAG-3 (mercapto-acetyl-triglycine)
D) 99mTc-dimercapto-succinic acid (DMSA)
E) 131I-meta-iodobenzyl-guanidine (MIBG)
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